{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:57:06Z","timestamp":1768463826184,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:00:00Z","timestamp":1539648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.hjc.2018.10.002","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T22:53:14Z","timestamp":1540075994000},"page":"249-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design"],"prefix":"10.1016","volume":"60","author":[{"given":"Aristi","family":"Boulmpou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Kartas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Farmakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanos","family":"Zafeiropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Nevras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4690-2865","authenticated-orcid":false,"given":"Athina","family":"Tampaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1539-6269","authenticated-orcid":false,"given":"Anastasia","family":"Vlachou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9968-7580","authenticated-orcid":false,"given":"Leonidas","family":"Lillis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Koutsakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haralampos","family":"Karvounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2018.10.002_bib1","series-title":"The Top 10 Causes of Death","author":"WHO","year":"2016"},{"issue":"2","key":"10.1016\/j.hjc.2018.10.002_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.hjc.2018.10.002_bib3","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hjc.2018.10.002_bib4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.hjc.2018.10.002_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.hjc.2018.10.002_bib6","first-page":"1","article-title":"Lipid testing and statin dosing after acute myocardial infarction","volume":"7","author":"Wang","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.hjc.2018.10.002_bib7","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.gheart.2014.03.1593","article-title":"PM208 Achievement of LDL-cholesterol goal with statins after an ST segment elevation myocardial infarction in a developing country","volume":"9","author":"Tungsubutra","year":"2014","journal-title":"Glob Heart"},{"issue":"1","key":"10.1016\/j.hjc.2018.10.002_bib8","first-page":"33","article-title":"Epidemiological characteristics and in-hospital management of acute coronary syndrome patients in Greece: results from the TARGET study","volume":"53","author":"Andrikopoulos","year":"2012","journal-title":"Hell J Cardiol"},{"issue":"4","key":"10.1016\/j.hjc.2018.10.002_bib9","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bcp.12339","article-title":"Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review","volume":"78","author":"De Vera","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.hjc.2018.10.002_bib10","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.01.014","article-title":"Therapeutic interventions and success in risk factor control for secondary prevention of stroke","volume":"18","author":"Alvarez-Sabin","year":"2009","journal-title":"J\u00a0Stroke Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.hjc.2018.10.002_bib11","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.295.2.180","article-title":"International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis","volume":"295","author":"Bhatt","year":"2006","journal-title":"JAMA J Am Med Assoc"},{"issue":"12","key":"10.1016\/j.hjc.2018.10.002_bib12","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.0000012530.68333.C8","article-title":"Withdrawal of statins increases event rates in patients with acute coronary syndromes","volume":"105","author":"Heeschen","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.hjc.2018.10.002_bib13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.hjc.2018.10.002_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/HJR.0b013e32832a4e7a","article-title":"Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review","volume":"16","author":"Neubeck","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.hjc.2018.10.002_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12875-015-0370-2","article-title":"Effectiveness of\u00a0motivational interviewing in patients with dyslipidemia: a randomized cluster trial","volume":"16","author":"B\u00f3veda-Font\u00e1n","year":"2015","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.hjc.2018.10.002_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.b4220","article-title":"Effect of tailored practice and patient care plans on secondary prevention of heart disease in general practice: cluster randomised controlled trial","volume":"339","author":"Murphy","year":"2009","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.hjc.2018.10.002_bib17","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.hjc.2018.10.002_bib18","article-title":"Interventions for improving modifiable risk factor control in the secondary prevention of stroke ( Review )","author":"Lager","year":"2014","journal-title":"Cochrane Libr"},{"issue":"20","key":"10.1016\/j.hjc.2018.10.002_bib19","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/eurheartj\/ehs184","article-title":"Third universal definition of myocardial infarction","volume":"33","author":"Thygesen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2018.10.002_bib20","first-page":"1","article-title":"Fourth universal definition of myocardial infarction (2018)","author":"Thygesen","year":"2018","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.hjc.2018.10.002_bib21","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1001\/archinte.167.16.1798","article-title":"Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: The heart and soul study","volume":"167","author":"Gehi","year":"2007","journal-title":"Arch Intern Med"},{"issue":"15","key":"10.1016\/j.hjc.2018.10.002_bib22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.hjc.2018.10.002_bib23","first-page":"2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction","volume":"294","author":"Pedersen","year":"2005","journal-title":"IDEAL Stud A Randomized Contr Trial"},{"issue":"3","key":"10.1016\/j.hjc.2018.10.002_bib24","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jacc.2006.04.070","article-title":"Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy","volume":"48","author":"Cannon","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.hjc.2018.10.002_bib25","first-page":"32","article-title":"Socioeconomic status and risk factors for cardiovascular disease: Impact of dietary mediators","volume":"58","author":"Psaltopoulou","year":"2017","journal-title":"Hell J Cardiol"},{"key":"10.1016\/j.hjc.2018.10.002_bib26","article-title":"Impact of metabolic syndrome on clinical severity and long-term prognosis in patients with myocardial infarction with ST-segment elevation","author":"Lovic","year":"2018","journal-title":"Hell J Cardiol"},{"issue":"4","key":"10.1016\/j.hjc.2018.10.002_bib27","first-page":"289","article-title":"Smoking impairs vagal modulation in old persons: the more we age, the more we learn","volume":"58","author":"Ioakeimidis","year":"2017","journal-title":"Hell J Cardiol"},{"issue":"19","key":"10.1016\/j.hjc.2018.10.002_bib28","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","year":"2001","journal-title":"JAMA J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.hjc.2018.10.002_bib29","first-page":"422","article-title":"Effect of statin pretreatment on the outcome of ST-segment elevation myocardial infarction in patients without prior history of coronary artery disease","volume":"54","author":"Mitas","year":"2013","journal-title":"Hell J Cardiol"},{"issue":"1","key":"10.1016\/j.hjc.2018.10.002_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mcna.2012.01.009","article-title":"LDL Cholesterol: the lower the better","volume":"96","author":"Martin","year":"2012","journal-title":"Med Clin North Am"},{"issue":"5","key":"10.1016\/j.hjc.2018.10.002_bib31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/fampra\/cmr025","article-title":"Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence","volume":"28","author":"Vashitz","year":"2011","journal-title":"Fam Pract"},{"issue":"2","key":"10.1016\/j.hjc.2018.10.002_bib32","first-page":"77","article-title":"Nurse-run, telephone-based outreach to improve lipids in people with diabetes","volume":"18","author":"Fischer","year":"2012","journal-title":"Am J Manag Care"},{"issue":"10","key":"10.1016\/j.hjc.2018.10.002_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0139997","article-title":"Nurse-led, telephone-based, secondary preventive follow-up after stroke or transient ischemic attack improves blood pressure and LDL cholesterol: Results from the first 12 months of the randomized, controlled NAILED stroke risk factor trial","volume":"10","author":"Irewall","year":"2015","journal-title":"PLoS One"},{"issue":"June","key":"10.1016\/j.hjc.2018.10.002_bib34","first-page":"1","article-title":"Pharmacist-led intervention to enhance medication adherence in patients with acute coronary syndrome in Vietnam: a randomized controlled trial","volume":"9","author":"Nguyen","year":"2018","journal-title":"Front Pharmacol"},{"issue":"Supplement 1","key":"10.1016\/j.hjc.2018.10.002_bib35","first-page":"337","article-title":"Nurse-led telephone-based follow-up of secondary prevention after acute myocardial infarction: One-year results from the randomized controlled NAILED-ACS trial","volume":"37","author":"Huber","year":"2016","journal-title":"PLoS One"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S110996661830349X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S110996661830349X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:12:42Z","timestamp":1761099162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S110996661830349X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S110996661830349X"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2018.10.002","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Motivational interviewing to support LDL-C therapeutic goals and lipid-lowering therapy compliance in patients with acute coronary syndromes (IDEAL-LDL) study: rationale and design","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2018.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}